Maiken Keson-Brookes has sold RUBY and made no open-market buys since Mar 2021
CLO, Corp. Secretary at Rubius Therapeutics, Inc.
SEC CIK 0001693805 · Filings on SEC.gov ↗
$0Bought
$506KSold
NoneLast buy
Every filing
1 filing since Mar 2021, newest first
Filings come from SEC EDGAR. Not investment advice.